There is no problem. You would be right, of course, if I was short the stock and was disseminating lies in an attempt to drive its price lower. But, that is not the case. In fact, it's just the opposite. My clients are long the stock and the information that I've stated is correct.
Also, you will notice in my original post, I didn't claim that Garrett met with Cymer's CEO, Dr. Robert Akins.
www4.techstocks.com
It was only during the midst of the emotional replies to my cautionary note that it suddenly became "Cymer's CEO". In his completely ballsed-up reply, Pierre addressed his posting to me and then proceeded to write as if he was addressing H.J.S.
To: Sunny Block (4324 )
From: Pierre
Oct 1 1997 6:43PM EST
Reply #4330 of 4528
Let's see if I've got this one right. Your hot shot buddy arranges
dinner with Dr. Akins for a little insider info and, probably over
cognac and cigars, says - Bob, I know you've been telling all
these other schmucks that all is well, but I'm a big shot so what's the real low down here." Dr. Akins responds "despite my many on the record statements that all is well, the truth, which I reveal only to big shots, is that this quarter is going to be a real boner."
The real story is as follows: On September 17, I participated in Garrett Van Wagoner's conference call for investment advisors. During the question and answer session, a question was raised about Cymer and whether any of the funds were still holding the stock, because at the end of August it was a top holding in the following funds: Emerging Growth = 4%, Mid-Cap = 4%, and Post Venture Capital = 5%. Garrett replied that most of the position had been sold at the time the company cancelled its conference appearance, but that he was having lunch with company executives on the following Monday to discuss recent developments.
The result is that the Van Wagoner funds have not bought CYMI back into the portfolios. This is publicly available knowledge. Please feel free to contact the firm and they will gladly confirm this fact. They will also explain the rationale behind the move.
So often it is claimed on this thread that "the facts" are all that matters. The problem is we do not have all of the facts concerning Cymers recent problems and the steps management has taken to deal with the situation. As a result, there is a good deal of uncertainty about the company's continued progress over the next few quarters - a fact that's been responsible for the lack of institutional commitment to the stock, even at these low levels.
P.S. I've been quite amused by all of your childish behaviour over the past week: the juvenile comments, the name-calling, and the extremely simple-minded reaction that anyone with a differing opinion must be a short-seller! But, perhaps the funniest of all has been your childish threat to "I'm going to tell on you", by sending our comments to Dr. Akins (as if he didn't have anything better to do than play nursemaid to some nervous investors). |
